Peroxisome proliferator-activated receptor (PPAR) alpha activation and its consequences in humans

Toxicology Letters

Volumn 102-103, Issue , 1998, Pages 85-90

  Hertz, Rachel ^a   Bar Tana, Jacob ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Fatty acids; Hepatocarcinogenesis; Hypolipidemic drugs; Peroxisome proliferators

Indexed keywords

BECLOBRATE; BEZAFIBRATE; CIPROFIBRATE; CLOFIBRATE; FENOFIBRATE; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PIRINIXIC ACID;

CARCINOGENESIS; CONFERENCE PAPER; DISORDERS OF PEROXISOMAL FUNCTIONS; FATTY ACID OXIDATION; HUMAN; HYPOLIPEMIA; IN VITRO STUDY; LIVER CELL; LIVER HYPERPLASIA; LIVER HYPERTROPHY; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; RODENT; SPECIES DIFFERENCE; TRANSCRIPTION REGULATION;

ANIMALS; ANTILIPEMIC AGENTS; HUMANS; LIVER; PEROXISOME PROLIFERATORS; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SPECIES SPECIFICITY; TRANSCRIPTION FACTORS;

RODENTIA;

EID: 0032439396     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(98)00290-2     Document Type: Conference Paper

References (40)

1. Ashby, J., Brady, A., Elcomb, C.R., et al., 1994. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Hum. Exp. Toxicol. 13, S1-S17.
2. Bichet, N.D., Cahard, D., Fabre, G., Remandet, B., Gouy, D., Cano, J.-P., 1990. Toxicological studies on a benzofuran derivative. Toxicol. Appl. Pharmacol. 106, 509-517.
3. Blaauboer, B.J., Van Holstein, C.W.M., Bleumink, R., et al., 1990. The effect of beclobric acid and clofibric acid on peroxisomal β-oxidation and peroxisome proliferation in primary cultures of rat, monkey and human hepatocytes. Biochem. Pharmacol. 40, 521-528.
4. Blümcke, S., Schwartzkopff, W., Lobeck, H., Edmondson, N.A., Prentice, D.E., Blane, G.F., 1983. Influence of fenofibrate on cellular and subcellular liver structure in hyperlipidemic patients. Atherosclerosis 46, 105-116.
5. Cattley, R.C., Kato, M., Popp, J.A., Voss, K.S., 1994. Initiator specific promotion of hepatocarcinogenesis by WT-14643 and clofibrate. Carcinogenesis 15, 1763-1766.
6. Chance, D.S., Wu, S.M., McIntosh, M.K., 1995. Inverse relationship between peroxisomal and mitochondrial β-oxidation in Hep-G2 cells treated with dehydroepiandrosterone and clofibric acid. Proc. Soc. Ex. Biol. Med. 208, 378-384.
7. Cornu-Chagnon, M.C., Dupont, H., Edgar, A., 1995. Fenofibrate: metabolism and species differences for peroxisome proliferation in cultured hepatocytes. Fundam. Appl. Toxicol. 26, 63-74.
8. De La Iglesia, F.A., Lewis, J.E., Buchanan, R.A., Marcus, G.L., McMahon, G., 1982. Light and electron microscopy of liver in hyperlipoproteinemic patients under long-term gemfibrozil treatment. Atherosclerosis 43, 19-37.
9. Elcomb, C.R., Bell, D.R., Elias, E., Hassmall, S.C., Plant, N.J., 1996. Peroxisome proliferators: species differences in response of primary hepatocyte cultures. Ann. N.Y. Acad. Sci. 804, 624-635.
10. Frenkel, B., Bishara-Shieban, J., Bar-Tana, J., 1994. The effect of β,β′-methyl-substituted hexadecanedioic acid on plasma VLDL metabolism in rats: role of apolipoprotein C-III. Biochem. J. 298, 409-414.
11. Frenkel, B., Mayorek, N., Hertz, R., Bar-Tana, J., 1988. The hypochylomicronemic effect of β,β′-methyl-substituted hexadecanedioic acid is mediated by a decrease in apolipoprotein C-III. J. Biol. Chem. 263, 8491-8497.
12. Gariot, P., Barrat, E., Drouin, P., et al., 1987. Morphometric study of human hepatic cell modifications induced by fenofibrate. Metabolism 36, 203-210.
13. Gibson, G., Lake, B., 1993. Peroxisomes - Biology and Importance in Toxicology and Medicine. Taylor and Francis, London.
14. Gray, R.H., De La Iglesia, F.A., 1984. Quantitative microscopy comparison of peroxisome proliferation by the lipid regulating agent gemfibrozil in several species. Hepatology 4, 520-530.
15. Hanefeld, M., Kemmer, C., Kander, E., 1983. Relationship between morphological changes and lipid-lowering action of p-chlorophenoxy isobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man. Atherosclerosis 46, 239-246.
16. Hertz, R., Arnon, J., Hoter, A., Shouval, D., Bar-Tana, J., 1987. Clofibrate does not induce peroxisomal proliferation in human hepatoma cell lines PLC/PRF/5 and SK-Hep-1. Cancer Lett. 34, 263-272.
17. Hertz, R., Berman, I., Bar-Tana, J., 1994. Transcriptional activation by amphipathic carboxylic peroxisomal proliferators is induced by the free acid rather than the acyl-CoA derivative. Eur. J. Biochem. 221, 611-615.
18. Hertz, R., Bishara-Shieban, J., Bar-Tana, J., 1995. Mode of action of peroxisome proliferators as hypolipidemic drugs: suppression of apolipoprotein C-III. J. Biol. Chem. 270, 13470-13475.
19. Hertz, R., Seckbach, M., Zakin, M., Bar-Tana, J., 1996. Transcriptional suppression of the transferrin gene by hypolipidemic peroxisome proliferators. J. Biol. Chem. 271, 218-224.
20. Hertz, R., Magenheim, J., Berman, I., Bar-Tana, J., 1998. Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4α. Nature 392, 512-516.
21. Huber, W.W., Grasl-Kraupp, B., Schulte-Hermann, R., 1996. Hepatocarcinogeneic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk. Crit. Rev. Toxicol. 26, 365-481.
22. Hwang, J.J., Hsia, M.T., Jirtle, R.L., 1993. Induction of sister chromatid exchange and micronuclei in primary cultures of rat and human hepatocytes by the peroxisome proliferator Wy-14643. Mutat. Res. 286, 123-133.
23. Inoue, I., Shino, K., Noji, S., Awata, T., Katagama, S., 1998. Expression of peroxisome proliferator-activated receptor alpha (PPARα) in primary cultures of human vascular endothelial cells. Biochem. Biophys. Res. Commun. 246, 370-374.
24. Isseman, I., Green, S., 1990. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347, 645-650.
25. Kliewer, S.P., Umesono, K., Noonan, D.J., Heyman, R.A., Evans, R.M., 1992. Convergence of 9-cis retinoic acid and peroxisome proliferators signalling pathways through heterodimer formation of their receptors. Nature 358, 771-774.
26. Lee, SS-T., Pineau, T., Drago, J., et al., 1995. Targeted disruption of the a isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell Biol. 15, 3012-3022.
27. Lemberger, T., Staels, B., Saladin, R., Desvergne, B., Auwerx, J., Wahli, W., 1994. Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids. J. Biol. Chem. 269, 24527-24530.
28. Mukherjee, R., Jow, L., Noonan, D., McDonnell, D.P., 1994. Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators. J. Steroid Biochem. Mol. Biol. 51, 157-166.
29. Osumi, T., Weh, J.K., Hashimoto, T., 1991. Two cis-acting regulatory elements in the peroxisome proliferator-response element enhancer region of the acyl-CoA oxidase gene. Biochim. Biophys. Res. Commun. 175, 866-871.
30. Palmer, C.N.A., Hsu, Mei-H., Griffin, K.J., Raucy, J.L., Johnson, E.F., 1998. Peroxisome proliferator activated receptor-α expression in human liver. Mol. Pharmacol. 53, 14-22.
31. Passily, P., Pacot, C., Jannin, B., et al., 1996. Toxicological evaluation of peroxisome proliferators. Ann. N.Y. Acad. Sci. 804, 716-718.
32. Rao, M.S., Reddy, J.K., 1987. Peroxisome proliferation and hepatocarcinogenesis. Carcinogenesis 8, 631-636.
33. Reddy, J.K., Rao, M.S., 1989. Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis. Mutat. Res. 214, 63-68.
34. Reddy, J.K., Suga, T., Mannaerts, G.P., Lazarow, P.B., Suberman, S., 1996. Peroxisomes - Biology and role in toxicology and disease. Ann. N.Y. Acad. Sci. Series, Vol. 804.
35. Sausen, P.J., Teets, V.J., Voss, K.S., Miller, R.T., Cattley, R.C., 1995. Gemfibrozil-induced peroxisome proliferation and hepatomegaly in male F-344 rats. Cancer Lett. 97, 263-268.
36. Sher, T., Yi, H.F., McBride, O.W., Gonzalez, F.J., 1993. cDNA cloning, chromosomal mapping and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry 32, 5598-55604.
37. Su, J.L., Simmons, C.J., Wisely, B., Ellis, B., Winegar, D.A., 1998. Monitoring of PPARa protein expression in human tissue by the use of PPARa specific Mabs. Hybridoma 17, 45-53.
38. Tugwood, J.D., Isseman, I., Anderson, R.G., Bundell, K.R., McPheat, W.L., Green, S., 1992. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl-CoA oxidase gene. Embo J. 11, 433-439.
39. Tugwood, J.D., Aldridge, T.C., Lambe, K.G., McDonald, N., Woodgatt, N.J., 1996. Peroxisome proliferator-activated receptors: structure and function. Ann. N.Y. Acad. Sci. 804, 252-265.
40. Varanasi, U., Chu, R., Huang, Q., Castellon, R., Yeldandi, A.V., Reddy, J.K., 1996. Identification of a peroxisome proliferator responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene. J. Biol. Chem. 271, 2147-2155.